Home/Filings/4/0001583810-20-000006
4//SEC Filing

LOSORDO DOUGLAS W 4

Accession 0001583810-20-000006

CIK 0000320017other

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 4:03 PM ET

Size

10.5 KB

Accession

0001583810-20-000006

Insider Transaction Report

Form 4
Period: 2020-01-13
LOSORDO DOUGLAS W
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2020-01-13+19,000135,197 total
  • Tax Payment

    Common Stock

    2020-01-13$3.28/sh2,601$8,531132,596 total
  • Award

    Stock Options (Right to Buy)

    2020-01-13+29,00029,000 total
    Exercise: $3.28From: 2020-01-13Exp: 2030-01-13Common Stock (29,000 underlying)
  • Tax Payment

    Common Stock

    2020-01-14$3.38/sh2,190$7,402130,406 total
Footnotes (3)
  • [F1]Represents 19,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
  • [F2]Includes 25,575 unvested restricted stock awards.
  • [F3]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.

Issuer

CALADRIUS BIOSCIENCES, INC.

CIK 0000320017

Entity typeother

Related Parties

1
  • filerCIK 0001583810

Filing Metadata

Form type
4
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 4:03 PM ET
Size
10.5 KB